Various claims and legal proceedings generally incidental to the normal course of business are pending or threatened on behalf of or against the Company.
In October 2018, the Company's Board of Directors authorized the repurchase of an additional $200,000,000 of the Company's common stock.
None.
None.
 ITEM 6.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
